Description
A carbonic anhydrase inhibitor (IC50 = 130 nM); reduces intraocular pressure and cerebrospinal fluid flow in a rat model of glaucoma; reduces electroshock-induced seizures in rats (ED50 = 19.2 mg/kg); inhibits production of ROS in a PCN cellular model of SAH; reduces cerebral edema in a mouse model of SAH; larvicidal against A. aegypti (LC50 = 724 ppm)
Formal name: N-[5-(aminosulfonyl)-3-methyl-1,3,4-thiadiazol-2(3H)-ylidene]-acetamide
Synonyms:
Molecular weight: 236.3
CAS: 554-57-4
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Small Molecule Inhibitors|Carbonic Anhydrase||Research Area|Neuroscience|Ophthalmology||Research Area|Neuroscience|Seizure Disorders||Research Area|Oxidative Stress & Reactive Species|Antioxidant Activity||Research Area|Oxidative Stress & Reactive Species|Reactive Oxygen